Targeting the thioredoxin system as a novel strategy against B‐cell acute lymphoblastic leukemia

B‐cell precursor acute lymphoblastic leukemia (BCP‐ALL) is a genetically heterogeneous blood cancer characterized by abnormal expansion of immature B cells. Although intensive chemotherapy provides high cure rates in a majority of patients, subtypes harboring certain genetic lesions, such as MLL rea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Oncol
Main Authors: Fidyt, Klaudyna, Pastorczak, Agata, Goral, Agnieszka, Szczygiel, Kacper, Fendler, Wojciech, Muchowicz, Angelika, Bartlomiejczyk, Marcin Adam, Madzio, Joanna, Cyran, Julia, Graczyk‐Jarzynka, Agnieszka, Jansen, Eugene, Patkowska, Elzbieta, Lech‐Maranda, Ewa, Pal, Deepali, Blair, Helen, Burdzinska, Anna, Pedzisz, Piotr, Glodkowska‐Mrowka, Eliza, Demkow, Urszula, Gawle‐Krawczyk, Karolina, Matysiak, Michal, Winiarska, Magdalena, Juszczynski, Przemyslaw, Mlynarski, Wojciech, Heidenreich, Olaf, Golab, Jakub, Firczuk, Malgorzata
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6487705/
https://ncbi.nlm.nih.gov/pubmed/30861284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12476
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados